SCHEMBL7652520

SCHEMBL7652520

COCCOc1cccc2cc(-c3ccccc3C(=O)Nc3ccc(C(=N)N)cc3)c(C(=O)OCc3ccccc3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK1 P06870 3/20 0.47
KLK5 Q9Y337 3/20 0.47
PLAU P00749 8/20 0.45
PLAT P00750 6/20 0.45
F10 P00742 9/20 0.44
F2 P00734 9/20 0.44
F7 P08709 4/20 0.44
F3 P13726 2/20 0.44
PRSS1 P07477 2/20 0.44
PRSS2 P07478 2/20 0.44
PRSS3 P35030 2/20 0.44
PLG P00747 4/20 0.41
AURKA O14965 1/20 0.40
AURKB Q96GD4 1/20 0.40
GAA P10253 2/20 0.39
SGMS2 Q8NHU3 1/20 0.39
F9 P00740 1/20 0.39
F11 P03951 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7664959 0.94 KLK1 (0.47) KLK1KLK5PLAUPLATF10
SCHEMBL7656182 0.91 KLK1 (0.47) KLK1KLK5PLAUPLATF10
SCHEMBL7655097 0.90 F10 (0.54) KLK1KLK5PLAUPLATF10
SCHEMBL7661922 0.89 KLK1 (0.48) KLK1KLK5PLAUPLATF10
SCHEMBL7662355 0.89 KLK1 (0.55) KLK1KLK5PLAUPLATF10
SCHEMBL7655653 0.89 KLK1 (0.52) KLK1KLK5PLAUPLATF10
SCHEMBL7653208 0.87 F10 (0.51) KLK1KLK5PLAUPLATF10
SCHEMBL7653220 0.87 KLK1 (0.48) KLK1KLK5PLAUPLATF10
SCHEMBL7654767 0.86 KLK1 (0.48) KLK1KLK5PLAUPLATF10
SCHEMBL7651959 0.84 F2 (0.51) KLK1KLK5PLAUPLATF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed